Pharma News In Brief
Executive Summary
New White House Advisory Panel On Competitiveness
You may also be interested in...
PhRMA's Policy Pitch: Protect Industry Innovation Or We Go The Way Of Auto Makers
Under new leadership, the Pharmaceutical Research and Manufacturers of America is making a strong pitch to Congress and the White House for regulatory and tax policy changes aimed at protecting innovation.
REMS For Obesity Drugs May Need More Specifics After Qnexa Advisory Panel
Providing the details of a risk management strategy would aid sponsors in their quest for a positive response to weight-loss drugs from FDA's Endocrinologic and Metabolic Drugs Advisory Committee, the panel indicated July 15 in its review of Vivus's Qnexa
PhRMA Chief Billy Tauzin Stepping Down
Billy Tauzin is stepping down as president and CEO of the Pharmaceutical Research and Manufacturers of America